|
|||||
|
|
|||||
| Case Report | |||||
| Volume 2, Number 3, June 2010, Page 137-139 | |||||
|
|
|||||
|
Rectal Metastasis of Prostate Cancer: About
a Case
Aurelien
Venaraa, Emilie
Thibaudeaua,
Souhil
Lebdaib,
Stephanie
Muccia,
Catherine
Ridereau-Zinsc,
Rahmene
Azzouzib,
Antoine
Hamya,
d
aDigestive
Surgery Department, chu Angers, 4 rue Larrey, 49000 Angers, France
Manuscript accepted for publication April 8, 2010
Abstract
Prostate
adenocarcinomas present a high risk of metastasis. We report a case of
an atypical prostate cancer metastasis. A male patient presented a
prostatic adenocarcinoma treated by surgery. A biological recurrence was
discovered during the follow-up by an increased rate of Prostate
Specific Antigen (PSA) and was treated by hormonotherapy. Several months
later, there was a re-increase of the PSA rate. The CT scan showed a
radiation proctitis aspect. An intermittent hormonotherapy was decided.
Six months later, he presented abdominal pain. Examinations were
performed and showed a rectal carcinosarcoma with prostate origins. A
surgical management was realised. The outcomes were an early recurrence.
A symptomatic treatment was decided. There are not any rectal
localisations reported in the literature. Only loco-regional invasions
of the rectum are described and no histological modification of
metastasis compared to the primitive tumor has been reported. So, we
report a metastasis of a prostate adenocarcinoma which transformed into
a carcinosarcoma. Keywords: Adenocarcinoma; Carcinosarcoma; Metastasis; Prostate; Rectal neoplasm
Introduction
Prostate
adenocarcinomas are highly metastatic cancers.
Elective
locations are
bones.
A recent review of the literature about metastatic
locations of prostate cancer did not report any isolated rectal
metastasis [1].
We describe a case of a 75 years old man who presented such a
metastasis. Case Report
A 75
years old male patient presented a prostate adenocarcinoma in July 1999,
confirmed by positive transrectal prostate biopsies and treated by
radical prostatectomy, seminal vesicles ablation, bilateral
ilio-obturator lymphadenectomy and vesico-uretral junction
reconstruction. Histology did not show any node metastasis on the 9
nodes from the ilio-obturator lymphadenectomy. A large adenocarcinoma
was found in the prostate with a Gleason score at
3 + 4 with an extra-capsular
extension and a multiple perineural extension. The seminal vesicles were
healthy. In the end of 2005, during his follow-up, an increased rate of
Prostate Specific Antigen (PSA) was discovered.
The
imaging
evaluation was
normal.
The follow-up of the PSA rate showed a progressive
increase reaching 6.85 ng/ml (N < 3). A RMI was performed in April 2006
which did not show any local recurrence. A treatment by hormonotherapy
and pelvic radiotherapy were performed which normalized the PSA rate. In
March 2008, one year after the end of the treatment, a new re-increase
of the PSA at 7.98 ng/ml was found. The imaging did not show any
recurrence. Only a circumferential thickening of the rectal wall was
found on the pelvic CT scan (Fig. 1). It was interpreted like a radic
rectitis. A treatment by intermittent hormonotherapy was then decided.
In January 2009, the patient presented abdominal pain with alteration of
his general condition. With the occurrence of an occlusive syndrome, an
abdominopelvic CT scan was realised. It showed a thickening of the
rectal wall with a tumour filling the rectal lumen. The density of the
tumour was lower than the walls (Fig. 2A). Rectoscopic biopsies were
performed and showed a sarcomatoid carcinoma. An RMI was realised, the
T2-weighted sequence showed a thick rectal wall with a heterogeneous
rectal tumor in hyper-signal (Fig. 2B). The T1-weighted sequence showed
a heterogeneous tumor filling the rectal lumen, fixed to the posterior
rectal wall (Fig. 2C). The patient underwent surgery in June 2009. He
had an anterior resection of the rectum without continuity
reestablishment and thus had a terminal left iliac colostomy instead.
The histological analysis found a prostatic carcinosarcoma with
intra-parietal focuses of rectal adenocarcinoma. The post-operative
period did not present any complication and the pain disappeared. The
patient was seen by the surgeon in August 2009. He was healthy and had a
PSA rate at 0.23 ng/ml. In September 2009, the patient consulted at the
emergency unit for proctorrhagia and rectal syndrome. A proctoscopy was
performed on the rectal stump and showed an early recurrence of the
carcinosarcoma with the same aspect as previously. A RMI was performed
in order to evaluate the tumoral volume. It showed the same type of
image as the previous RMI. There was a heterogeneous T2 hyper-signal and
T1 hypo-signal tumor filling the whole rectal lumen. The case was
discussed in a pluridisciplinary meeting which decided that the
management of this patient would be a radiofrequency treatment with
comfort-care. This treatment is currently in process.
Prostatic adenocarcinoma presents a high risk of metastasis. The most frequent localization is the bones with more than 90% of the long-term metastasis [1]. Several other localizations were reported including the small intestine (1 - 4%) and the caecum, but never the rectum. A suspicion of metastasis was reported after transrectal prostate biopsy [2], it seemed to be sub-mucosa nodules which have been resected by endoscopy. There was no increase of the PSA rate contrary to our case. Some autopsy series revealed that 9% of the patients who presented prostate adenocarcinoma had a contiguity invasion of the rectum [3]. In those cases, there were digestive symptoms which could reveal advanced prostate cancer. In our case, we exclude a contiguity invasion because of the delay with the prime surgery, and because of the fact that the adenocarcinoma was encapsulated. However, no rectal invasion was seen during the initial procedure. Thus, it seems to be a rectal metastasis of the prostate adenocarcinoma by distant contamination. However, the histological differences between the metastasis and the initial tumor imply a mutation of a prostatic adenocarcinoma into a prostatic carcinosarcoma. This mutation could be spontaneous or induced by the radiotherapy. Carcinosarcoma of the colon is a rare tumour with both epithelial and sarcomatous components. Histogenesis from a common cell progenitor [4] has been reported. No secondary prostatic carcinosarcomas in the rectum were described in the literature. Also, several cases of prostatic carcinosarcoma were described with metastasis but none was described with metastasis on the colon [5]. Moreover, this case reports an adenocarcinoma transformation into a carcinosarcoma probably induced by the radiotherapy performed for the prostate cancer recurrence treatment. This case is also the first which reports a metastasis different from the primitive cancer.
Thus,
this report presents a double interest: it describes an unusual
metastasis site for prostate cancer and also a histological modification
of the tumor probably induced by radiotherapy. |
|||||
|
|
|||||
| References | |||||
| 1. |
Lebret T, Mejean A. [Rare locations of metastases from prostate cancer].
Prog Urol 2008;18 Suppl 7(357-364). [Medline] |
| 2. |
Vaghefi H, Magi-Galluzzi C, Klein EA. Local recurrence of prostate
cancer in rectal submucosa after transrectal needle biopsy and radical
prostatectomy. Urology 2005;66(4):881. [Medline] [CrossRef] |
| 3. |
Bowrey DJ, Otter MI, Billings PJ. Rectal infiltration by prostatic
adenocarcinoma: report on six patients and review of the literature. Ann
R Coll Surg Engl 2003;85(6):382-385. [Medline] [CrossRef] |
| 4. |
Ambrosini-Spaltro A, Vaira V, Braidotti P, Rovati MP, Ferrero S, Bosari
S. Carcinosarcoma of the colon: report of a case with morphological,
ultrastructural and molecular analysis. BMC Cancer 2006;12(6):185. [Medline] |
| 5. |
Subramanian VS, Coburn M, Miles BJ. Carcinosarcoma of the prostate with
multiple metastases: case report and review of the literature. Urol
Oncol 2005;23(3):181-183. [Medline] [CrossRef] |
Digital Object Identifier (DOI):10.4021/jocmr2010.05.309w
About
DOI and
CrossRef
Journal of Clinical Medicine Research is a member of CrossRef.